Ayala Pharmaceuticalsの売上総利益

Ayala Pharmaceuticalsの売上総利益 は何ですか。

Ayala Pharmaceuticals Inc.の売上総利益 は100.00%です。

売上総利益 の定義は何ですか。



売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

NASDAQのセクタHealth Careにおける売上総利益 の企業と比べるAyala Pharmaceuticals

Ayala Pharmaceuticalsは何をしますか。

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Ayala Pharmaceuticalsと類似の売上総利益